Cargando…
Hemophagocytic syndrome and COVID-19
The case of a woman hospitalized due to COVID-19 is presented. The patient developed a severe macrophage activation syndrome diagnosed by bone marrow biopsy, which did not respond to immunoglobulin therapy.
Autores principales: | Lima, Ricardo, Filho, Célio Cortinhas, Ferreira Filho, Carlos Martins, Vaisman, Mauricio, Cossenza, Alexandre, Rebello, Caroline Pinto, Leite, Carolina de Andrade, de Oliveira Tavares, Danilo, Ramalho, Julia Falconiere |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347481/ https://www.ncbi.nlm.nih.gov/pubmed/32704472 http://dx.doi.org/10.1016/j.rmcr.2020.101162 |
Ejemplares similares
-
Implementation and Effectiveness of a Pharmacotherapeutic Follow-Up Service for People with Tuberculosis in Primary Healthcare
por: Lara-Júnior, Célio Rezende, et al.
Publicado: (2022) -
In vitro behaviour of endothelial cells on a titanium surface
por: Breithaupt-Faloppa, Ana Cristina, et al.
Publicado: (2008) -
Hemophagocytic syndrome: a dilemma chasing the intensivists
por: Queiroz, Adriana Façanha, et al.
Publicado: (2015) -
Possible intrauterine transmission of SARS-CoV-2: Ultrasound findings and viral molecular detection in amniotic fluid
por: Maia, Maria Carolina Andrade, et al.
Publicado: (2022) -
Possible intrauterine transmission of SARS-CoV-2: Ultrasound findings and viral molecular detection in amniotic fluid
por: Maia, Maria Carolina Andrade, et al.
Publicado: (2022)